DNDN

Dendreon Corporation News Headlines

$2.6699
*  
0.0201
 negative 
0.75%
Get DNDN Alerts
*Delayed - data as of Apr. 16, 2014 13:44 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    DNDN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Is ?Less Bad? As Good As It Gets For Dendreon? (DNDN, JNJ, MDVN, SNY)
11/5/2012 1:04:00 PM - Investopedia

Weekly Stock Watch, Week Of November 5
11/5/2012 7:45:00 AM - Seeking Alpha

Biotech Weekend Recap: Earnings Reports
11/5/2012 4:26:00 AM - Seeking Alpha

Mid-Afternoon Market Update: Markets Remain Down
11/2/2012 3:49:38 PM - Benzinga

Benzinga Mid-Day Market Update
11/2/2012 12:55:39 PM - Benzinga

Benzinga Mid-Morning Market Update
11/2/2012 10:54:39 AM - Benzinga

Redemption Still Possible For 2 Fallen Biotech Stocks
11/1/2012 2:13:00 PM - Seeking Alpha

Mid-Week Stock Watch, Week Of 29 October
11/1/2012 8:54:00 AM - Seeking Alpha

Stock Market News for October 30, 2012 - Market News
10/30/2012 10:06:01 AM - Zacks.com

Today's Market News: 5 Stocks Affected By Hurricane Sandy
10/30/2012 9:38:00 AM - Seeking Alpha

Weekly Stock Watch, Week Of 29 October
10/29/2012 11:57:00 AM - Seeking Alpha

Weekly Stock Watch For October 22, 2012
10/22/2012 5:01:00 PM - Seeking Alpha

Will Dendreon Surprise The Street On October 30?
10/22/2012 9:42:00 AM - Seeking Alpha

Weekly Stock Watch, Week Of 15 October, 2012
10/15/2012 4:10:00 PM - Seeking Alpha

Biotech Investors: Are We Blinded By Clinical Trials?
10/15/2012 8:45:00 AM - Seeking Alpha

Dendreon's Provenge: Under Attack Once Again
10/15/2012 2:50:00 AM - Seeking Alpha

Dendreon Treads the Neutral Path - Analyst Blog
10/11/2012 5:25:01 PM - Zacks.com

Dendreon's Provenge: More Evidence Of A Greater Life Extension Survival Benefit
10/2/2012 12:29:00 PM - Seeking Alpha

What Next For Neuralstem?
10/2/2012 10:09:00 AM - Seeking Alpha

Can Dendreon Stop The Medivation Invasion?
10/2/2012 7:15:00 AM - Seeking Alpha

Can Stem Cells Regenerate Your Portfolio? Stephen Dunn Says Yes
9/28/2012 9:21:00 AM - Seeking Alpha

2 Fundamental Reasons To Consider ViroPharma, Inc. In The Wake Of A Recent Upgrade
9/24/2012 10:57:00 AM - Seeking Alpha

Saddling Up The One-Trick Biotech Pony And Getting Bucked Off: The Questcor Example
9/21/2012 6:23:00 AM - Seeking Alpha

IPO Preview: GlobeImmune
9/19/2012 12:02:00 PM - Seeking Alpha

NeoStem: A Promising Investment Candidate In Stem Cell Treatment
9/17/2012 8:25:00 AM - Seeking Alpha